Questionnaire

1. In the DISCOVER study programme what was the average HbA1c in 40% of South African patients when a second therapeutic agent was added to metformin?

2. Lack of progression of type 2 diabetes therapy is likely due to:

3. Primary care practice trials need to:

4. The LIRA-PRIME trial was conducted in multiple primary care practices:

5. On top of adequate maximum tolerated dose of metformin, which of the following agents were not included in LIRA-PRIME as commonly used in patient-centred care:

6. The HbA1c of patients included in the LIRA-PRIME trial was:

7. In the LIRA-PRIME trial the primary endpoint of inadequate control (>7% at two consecutive visits) was how long in the OAD group?

8. In the LIRA-PRIME trial, liraglutide maintained control (<7% for two visits) for:

9. How many patients were treated with liraglutide?

10. Premature treatment discontinuation occurred later in patients treated with liraglutide versus any OAD: